<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="16026409-e821-4680-a114-24c1761d6690"><labelDrug name="Zaroxolyn"><Normalization><mmtx cui="C0701383" preferredWord="Zaroxolyn" semType="phsu, orch"/></Normalization></labelDrug><generic name="metolazone"/><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1" text="Drug Label for drug brand Zaroxolyn, containing metolazone." type="negative"><entity charOffset="26:35" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.0" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="Drug Label for drug brand Zaroxolyn," preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Zaroxolyn," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="48:58" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.2" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="metolazone." preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.1.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6" text="DO NOT INTERCHANGE ZAROXOLYN TABLETS AND OTHER FORMULATIONS OF METOLAZONE THAT SHARE ITS SLOW AND INCOMPLETE BIOAVAILABILITY AND ARE NOT THERAPEUTICALLY EQUIVALENT AT THE SAME DOSES TO MYKROX TABLETS, A MORE RAPIDLY AVAILABLE AND COMPLETELY BIOAVAILABLE METOLAZONE PRODUCT. " type="negative"><entity charOffset="63:73" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.0" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="OTHER FORMULATIONS OF METOLAZONE" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="254:264" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="COMPLETELY BIOAVAILABLE METOLAZONE PRODUCT." preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="185:191" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.2" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="TO MYKROX TABLETS," preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="19:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.3" text="zaroxolyn tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="NOT INTERCHANGE ZAROXOLYN TABLETS" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.6.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.7" text="FORMULATIONS BIOEQUIVALENT TO ZAROXOLYN AND FORMULATIONS BIOEQUIVALENT TO MYKROX SHOULD NOT BE INTERCHANGED FOR ONE ANOTHER." type="negative"><entity charOffset="74:80" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.7.e.0" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="BIOEQUIVALENT TO MYKROX" preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.7.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="BIOEQUIVALENT TO ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.7.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.7.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9" text="ZAROXOLYN Tablets (metolazone tablets, USP) for oral administration contain 2 or 5 mg of metolazone, USP, a diuretic/saluretic/antihypertensive drug of the quinazoline class." type="negative"><entity charOffset="0:17" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" text="zaroxolyn tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="ZAROXOLYN Tablets" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="81:99" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" text="5 mg metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0987840" phraseText="5 mg of metolazone," preferredWord="Metolazone 5 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="117:126" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2" text="saluretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0597421" phraseText="a diuretic/saluretic/antihypertensive drug of the quinazoline class." preferredWord="saluretic" semType="phsu"/><RxNorm RxCui="91215"/></Normalization></entity><entity charOffset="127:143" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="a diuretic/saluretic/antihypertensive drug of the quinazoline class." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="108:116" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic/saluretic/antihypertensive drug of the quinazoline class." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="117:148" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5" text="saluretic drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0304487" phraseText="a diuretic/saluretic/antihypertensive drug of the quinazoline class." preferredWord="Saluretic drug" semType="phsu"/><RxNorm RxCui="91215"/></Normalization></entity><entity charOffset="19:37" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" text="metolazone tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="(metolazone tablets," preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="127:148" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7" text="antihypertensive drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="a diuretic/saluretic/antihypertensive drug of the quinazoline class." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.5" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.6" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.9.e.7"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.10" text="Metolazone has the molecular formula C16H16ClN3S, the chemical name 7-chloro-1, 2, 3, 4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide, and a molecular weight of 365.83. " type="negative"><entity charOffset="129:132" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.10.e.0" text="oxo" type="Biomedical_Entity"><Normalization><mmtx cui="C0393003" phraseText="4-oxo-6-quinazolinesulfonamide," preferredWord="potassium oxonate" semType="phsu, orch"/><RxNorm RxCui="1427084"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.10.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="Metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.10.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.10.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.13" text="Inactive Ingredients: Magnesium stearate, microcrystalline cellulose and dye: 2 mg-D - C Red No. " type="negative"><entity charOffset="22:40" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.13.e.0" text="magnesium stearate" type="Biomedical_Entity"><Normalization><mmtx cui="C0126791" phraseText="Magnesium stearate," preferredWord="Magnesium stearate" semType="phsu, lipd"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="42:68" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.13.e.1" text="microcrystalline cellulose" type="Biomedical_Entity"><Normalization><mmtx cui="C3255827" phraseText="microcrystalline cellulose" preferredWord="micro-crystalline cellulose" semType="phsu"/><RxNorm RxCui="1239123"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.13.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.13.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18" text="ZAROXOLYN (metolazone) is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. " type="negative"><entity charOffset="40:48" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="11:21" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="(metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="91:109" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.2" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="generally similar to the thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.3" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.18.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.19" text="The actions of ZAROXOLYN result from interference with the renal tubular mechanism of electrolyte reabsorption. " type="negative"><entity charOffset="86:97" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.19.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="of electrolyte reabsorption." preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="15:24" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.19.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="The actions of ZAROXOLYN result" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.19.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.19.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20" text="ZAROXOLYN acts primarily to inhibit sodium reabsorption at the cortical diluting site and to a lesser extent in the proximal convoluted tubule. " type="negative"><entity charOffset="36:42" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="sodium reabsorption at the cortical diluting site" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.1" text="cortical" type="Biomedical_Entity"><Normalization><mmtx cui="C0205704" phraseText="sodium reabsorption at the cortical diluting site" preferredWord="Cascara sagrada" semType="phsu, orch"/><RxNorm RxCui="1029075"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.2" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.20.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.22" text="The increased delivery of sodium to the distal tubular exchange site results in increased potassium excretion. " type="negative"><entity charOffset="26:32" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.22.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="The increased delivery of sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="90:99" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.22.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="results in increased potassium excretion." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.22.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.22.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24" text="A proximal action of metolazone has been shown in humans by increased excretion of phosphate and magnesium ions and by a markedly increased fractional excretion of sodium in patients with severely compromised glomerular filtration. " type="negative"><entity charOffset="83:92" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.0" text="phosphate" type="Biomedical_Entity"><Normalization><mmtx cui="C0031603" phraseText="of phosphate" preferredWord="inorganic phosphate" semType="inch, phsu"/><RxNorm RxCui="486961"/></Normalization></entity><entity charOffset="164:170" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="fractional excretion of sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="21:31" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.2" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="A proximal action of metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.24.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31" text="The diuretic potency of ZAROXOLYN at maximum therapeutic dosage is approximately equal to thiazide diuretics. " type="negative"><entity charOffset="90:108" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.0" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="approximately equal to thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="The diuretic potency of ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="4:12" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.2" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="The diuretic potency of ZAROXOLYN" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.31.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.32" text="However, unlike thiazides, ZAROXOLYN may produce diuresis in patients with glomerular filtration rates below 20 mL/min." type="negative"><entity charOffset="16:25" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.32.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="unlike thiazides," preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="27:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.32.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.32.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.32.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33" lineNumber="32" text="ZAROXOLYN and furosemide administered concurrently have produced marked diuresis in some patients where edema or ascites was refractory to treatment with maximum recommended doses of these or other diuretics administered alone. " type="regular"><entity charOffset="0:9" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="14:24" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.1" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="72:80" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.2" text="diuresis" type="Specific_Interaction"/><entity charOffset="113:148" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.4" text="ascites was refractory to treatment" type="SPAN"/><entity charOffset="104:109|121:148" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.5" text="edema was refractory to treatment" type="SPAN"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.2"><relations><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.5" ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.1" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.33.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.42" text="&lt;item&gt;ZAROXOLYN is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. " type="negative"><entity charOffset="104:126" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.42.e.0" text="antihypertensive drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="with other antihypertensive drugs" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="6:15" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.42.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="&gt;ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.42.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.42.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.43" text="MYKROX Tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. " type="negative"><entity charOffset="0:6" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.43.e.0" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="MYKROX Tablets," preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="49:59" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.43.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="a more rapidly available form of metolazone," preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.43.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.43.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.44" text="A dose titration is necessary if MYKROX Tablets are to be substituted for ZAROXOLYN in the treatment of hypertension. " type="negative"><entity charOffset="74:83" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.44.e.0" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="substituted for ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="33:39" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.44.e.1" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="MYKROX Tablets" preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.44.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.44.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.60" text="Rarely, the rapid onset of severe hyponatremia and/or hypokalemia has been reported following initial doses of thiazide and non-thiazide diuretics. " type="negative"><entity charOffset="111:119" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.60.e.0" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="initial doses of thiazide" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="128:146" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.60.e.1" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="non-thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.60.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.60.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66" text="Serum potassium should be determined at regular and appropriate intervals, and dose reduction, potassium supplementation or addition of a potassium-sparing diuretic instituted whenever indicated. " type="negative"><entity charOffset="6:15" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="138:164" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.1" text="potassium-sparing diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="addition of a potassium-sparing diuretic" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="95:120" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.2" text="potassium supplementation" type="Biomedical_Entity"><Normalization><mmtx cui="C0561938" phraseText="potassium supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.66.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71" lineNumber="72" text="In general, diuretics should not be given concomitantly with lithium because they reduce its renal clearance and add a high risk of lithium toxicity. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="89:92" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.3" text="its" type="Expression"/><antecedentEntity charOffset="61-68" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.4" text="lithium" type="Drug"/></anaphoraRelation><entity charOffset="12:21" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="In general, diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="82:88|93:108" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.1" text="reduce renal clearance" type="Increase_Interaction"/><entity charOffset="61:68" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.4" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="140:148" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.6" text="toxicity" type="Increase_Interaction"/><entity charOffset="132:139" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.8" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.3" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.8" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72" lineNumber="72" text="Read prescribing information for lithium preparations before use of such concomitant therapy." type="irregular"><entity charOffset="0:28" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.e.0" text="Read prescribing information" type="Caution_Interaction"/><entity charOffset="33:53" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.e.2" text="lithium preparations" type="Drug_Class"><Normalization><mmtx cui="C0023870" phraseText="prescribing information for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71" text="In general, diuretics should not be given concomitantly with lithium because they reduce its renal clearance and add a high risk of lithium toxicity. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.71.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.72.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74" lineNumber="76" text="Unusually large or prolonged losses of fluids and electrolytes may result when ZAROXOLYN is administered concomitantly to patients receiving furosemide (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="79:88" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="141:151" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.1" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="29:62" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.2" text="losses of fluids and electrolytes" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.2"><relations><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.1" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.74.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76" lineNumber="80" text="When ZAROXOLYN is used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy." type="regular"><entity charOffset="97:134" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.0" text="excessive reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="5:14" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.2" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="34:56" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.3" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="used with other antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.3" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.76.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78" text="Cross-allergy may occur when ZAROXOLYN is given to patients known to be allergic to sulfonamide-derived drugs, thiazides, or quinethazone." type="negative"><entity charOffset="84:95" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="allergic to sulfonamide-derived drugs," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="29:38" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="111:120" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.2" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazides," preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="125:137" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.3" text="quinethazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0164608" phraseText="quinethazone." preferredWord="quinethazone" semType="phsu, orch"/><RxNorm RxCui="59743"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.78.e.3"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83" text="DO NOT INTERCHANGE ZAROXOLYN TABLETS AND OTHER FORMULATIONS OF METOLAZONE THAT SHARE ITS SLOW AND INCOMPLETE BIOAVAILABILITY AND ARE NOT THERAPEUTICALLY EQUIVALENT AT THE SAME DOSES TO MYKROX TABLETS, A MORE RAPIDLY AVAILABLE AND COMPLETELY BIOAVAILABLE METOLAZONE PRODUCT. " type="negative"><entity charOffset="254:264" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.0" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="COMPLETELY BIOAVAILABLE METOLAZONE PRODUCT." preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="19:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.1" text="zaroxolyn tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="NOT INTERCHANGE ZAROXOLYN TABLETS" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="185:191" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.2" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="TO MYKROX TABLETS," preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="63:73" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.3" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="OTHER FORMULATIONS OF METOLAZONE" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.83.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.84" text="FORMULATIONS BIOEQUIVALENT TO ZAROXOLYN AND FORMULATIONS BIOEQUIVALENT TO MYKROX SHOULD NOT BE INTERCHANGED FOR ONE ANOTHER." type="negative"><entity charOffset="74:80" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.84.e.0" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="BIOEQUIVALENT TO MYKROX" preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.84.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="BIOEQUIVALENT TO ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.84.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.84.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87" text="All patients receiving therapy with ZAROXOLYN Tablets should have serum electrolyte measurements done at appropriate intervals and be observed for clinical signs of fluid and/or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="72:83" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="serum electrolyte measurements" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="36:53" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.1" text="zaroxolyn tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="therapy with ZAROXOLYN Tablets" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="178:189" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.2" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92" lineNumber="100" text="The risk of hypokalemia is increased when larger doses are used, when diuresis is rapid, when severe liver disease is present, when corticosteroids are given concomitantly, when oral intake is inadequate or when excess potassium is being lost extrarenally, such as with vomiting or diarrhea." type="irregular"><entity charOffset="12:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.e.0" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="132:147" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.e.2" text="corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87" text="All patients receiving therapy with ZAROXOLYN Tablets should have serum electrolyte measurements done at appropriate intervals and be observed for clinical signs of fluid and/or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. "><entity charOffset="36:53" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.87.e.0" text="ZAROXOLYN Tablets" type="Drug"><Normalization><mmtx cui="C1242748" phraseText="therapy with ZAROXOLYN Tablets" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.88" text="In patients with severe edema accompanying cardiac failure or renal disease, a low-salt syndrome may be produced, especially with hot weather and a low-salt diet. "/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.89" text="Serum and urine electrolyte determinations are particularly important when the patient has protracted vomiting, severe diarrhea, or is receiving parenteral fluids. "/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.90" text="Warning signs of imbalance are: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscle fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting. "/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.91" text="Hyponatremia may occur at any time during long term therapy and, on rare occasions, may be life threatening."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.92.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.93" text="Thiazide-like diuretics have been shown to increase the urinary excretion of magnesium, this may result in hypomagnesemia." type="negative"><entity charOffset="0:8" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.93.e.0" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazide-" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.93.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="like diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.93.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.93.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.95" text="Metolazone may raise blood glucose concentrations possibly causing hyperglycemia and glycosuria in patients with diabetes or latent diabetes." type="negative"><entity charOffset="27:34" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.95.e.0" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="blood glucose concentrations possibly" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.95.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="Metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.95.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.95.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105" lineNumber="122" text="Orthostatic hypotension may occur, this may be potentiated by alcohol, barbiturates, narcotics, or concurrent therapy with other antihypertensive drugs." type="irregular"><entity charOffset="0:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.0" text="Orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="potentiated by alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="71:83" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="85:94" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics," preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="129:151" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="concurrent therapy with other antihypertensive drugs." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.102" text="Use caution when administering ZAROXOLYN Tablets to patients with severely impaired renal function. "><entity charOffset="31:48" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.102.e.0" text="ZAROXOLYN Tablets" type="Drug"><Normalization><mmtx cui="C1242748" phraseText="administering ZAROXOLYN Tablets to patients" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.103" text="As most of the drug is excreted by the renal route, accumulation may occur."/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.104" text="Orthostatic Hypotension"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.105.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107" lineNumber="126" text="Hypercalcemia may infrequently occur with metolazone, especially in patients taking high doses of vitamin D or with high bone turnover states, and may signify hidden hyperparathyroidism. " type="regular"><entity charOffset="98:107" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.0" text="vitamin D" type="Drug"><Normalization><mmtx cui="C0014695" phraseText="high doses of vitamin D" preferredWord="Ergocalciferol" semType="phsu, orch, vita"/><mmtx cui="C0042866" phraseText="high doses of vitamin D" preferredWord="Vitamin D" semType="phsu, orch, vita"/><mmtx cui="C2936842" phraseText="high doses of vitamin D" preferredWord="Vitamin D [EPC]" semType="phsu"/><mmtx cui="C3537249" phraseText="high doses of vitamin D" preferredWord="D Vitamin" semType="phsu"/><RxNorm RxCui="604318"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.1" text="Hypercalcemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020437" phraseText="Hypercalcemia" preferredWord="Hypercalcemia" semType="dsyn"/></Normalization></entity><entity charOffset="42:52" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.3" text="metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="occur with metolazone," preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="166:185" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.4" text="hyperparathyroidism" type="Specific_Interaction"><Normalization><mmtx cui="C0020502" phraseText="hidden hyperparathyroidism." preferredWord="Hyperparathyroidism" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.0" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.107.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.110" text="Thiazide diuretics have exacerbated or activated systemic lupus erythematosus and this possibility should be considered with ZAROXOLYN Tablets." type="negative"><entity charOffset="125:142" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.110.e.0" text="zaroxolyn tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="considered with ZAROXOLYN Tablets." preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="0:18" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.110.e.1" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="Thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.110.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.110.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115" lineNumber="140" text="Furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes (see WARNINGS)." type="regular"><entity charOffset="0:10" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.0" text="Furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="Furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="30:44" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.1" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0354100" phraseText="other loop diuretics" preferredWord="Loop Diuretics" semType="phsu"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="70:80" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.2" text="metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="concomitantly with metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="120:152" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.3" text="losses of fluid and electrolytes" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.2" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.2" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.115.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117" lineNumber="144" text="When ZAROXOLYN Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy. " type="regular"><entity charOffset="67:71" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.0" text="care" type="Caution_Interaction"/><entity charOffset="5:14" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.2" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C1242748" phraseText="ZAROXOLYN Tablets" preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="43:65" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.3" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="used with other antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.3" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118" lineNumber="144" text="Dosage adjustments of other antihypertensives may be necessary." type="irregular"><entity charOffset="0:18" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.e.0" text="Dosage adjustments" type="Caution_Interaction"/><entity charOffset="28:45" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.e.2" text="antihypertensives" type="Drug_Class"><Normalization><mmtx cui="C0350167" phraseText="Dosage adjustments of other antihypertensives" preferredWord="Antihypertensives, Other" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117" text="When ZAROXOLYN Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119" text="Alcohol, Barbiturates, And Narcotics" type="negative"><entity charOffset="27:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.0" text="narcotics" type="Biomedical_Entity"><Normalization><mmtx cui="C0027415" phraseText="Narcotics" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.1" text="barbiturates" type="Biomedical_Entity"><Normalization><mmtx cui="C0004745" phraseText="Barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120" lineNumber="148" text="The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119" Text="Alcohol, Barbiturates, And Narcotics"/><anaphoraEntity charOffset="27:38" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.0" text="these drugs" type="Expression"/><antecedentEntity charOffset="0:7" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.0" text="Alcohol" type="Substance"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119" Text="Alcohol, Barbiturates, And Narcotics"/><anaphoraEntity charOffset="27:38" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.0" text="these drugs" type="Expression"/><antecedentEntity charOffset="9:21" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.1" text="Barbiturates" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119" Text="Alcohol, Barbiturates, And Narcotics"/><anaphoraEntity charOffset="27:38" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.0" text="these drugs" type="Expression"/><antecedentEntity charOffset="27:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119.e.2" text="Narcotics" type="Drug_Class"/></anaphoraRelation><entity charOffset="4:23|46:57" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.1" text="hypotensive effects potentiated" type="Specific_Interaction"/><entity charOffset="112:122" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.3" text="metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="associated with metolazone therapy." preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.1"><relations><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.3" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122" lineNumber="152" text="Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. " type="regular"><entity charOffset="0:8" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.0" text="Diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic-induced hypokalemia" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="79:88" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.1" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="to digitalis." preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="17:28" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.2" text="hypokalemia" type="SPAN"/><entity charOffset="33:75" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.3" text="increase the sensitivity of the myocardium" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.3"><relations><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.2" ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.1" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.123" lineNumber="152" text="Serious arrhythmias can result." type="irregular"><entity charOffset="8:19" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.123.e.0" text="arrhythmias" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.123.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.123.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122" text="Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122" text="Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125" lineNumber="156" text="May increase the risk of hypokalemia and increase salt and water retention." type="irregular"><entity charOffset="25:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.0" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="41:54|65:74" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.2" text="increase salt retention" type="Specific_Interaction"/><entity charOffset="41:49|59:74" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.4" text="increase water retention" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="0:15" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.0" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="19:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.1" text="ACTH" type="Drug"/></ellipsisSentence></relation><relation type="hasObject"><labelDrug text="Zaroxolyn"/><normalization><mmtx><preferredWord>Zaroxolyn</preferredWord><phraseText>ZAROXOLYN</phraseText><cuiCode>C0701383</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="0:15" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.0" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="19:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.1" text="ACTH" type="Drug"/></ellipsisSentence></relation><relation type="hasObject"><labelDrug text="Zaroxolyn"/><normalization><mmtx><preferredWord>Zaroxolyn</preferredWord><phraseText>ZAROXOLYN</phraseText><cuiCode>C0701383</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.ddi.3"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="0:15" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.0" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"><entity charOffset="19:23" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124.e.1" text="ACTH" type="Drug"/></ellipsisSentence></relation><relation type="hasObject"><labelDrug text="Zaroxolyn"/><normalization><mmtx><preferredWord>Zaroxolyn</preferredWord><phraseText>ZAROXOLYN</phraseText><cuiCode>C0701383</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127" lineNumber="160" text="Serum lithium levels may increase (see WARNINGS)." type="irregular"><entity charOffset="0:5|14:20|25:33" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127.e.0" text="Serum levels increase" type="Increase_Interaction"/><entity charOffset="6:13" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="Serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117" text="When ZAROXOLYN Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.117.e.2"/></ellipsisSentence><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.118" text="Dosage adjustments of other antihypertensives may be necessary."/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.119" text="Alcohol, Barbiturates, And Narcotics"/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.120" text="The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy."/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.121" text="Digitalis Glycosides"/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.122" text="Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. "/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.123" text="Serious arrhythmias can result."/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.124" text="Corticosteroids Or ACTH"/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.125" text="May increase the risk of hypokalemia and increase salt and water retention."/><middleSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.126" text="Lithium"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.127.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129" lineNumber="164" text="Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. " type="regular"><entity charOffset="75:91" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0" text="curariform drugs" type="Drug_Class"><Normalization><mmtx cui="C0010464" phraseText="neuromuscular blocking effects of curariform drugs" preferredWord="Neuromuscular Nondepolarizing Agents" semType="phsu"/><mmtx cui="C0010464" phraseText="neuromuscular blocking effects of curariform drugs" preferredWord="Neuromuscular Nondepolarizing Agents" semType="phsu"/><RxNorm RxCui="706832"/></Normalization></entity><entity charOffset="101:113" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="such as tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.3" text="Diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic-induced hypokalemia" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="17:28" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.4" text="hypokalemia" type="SPAN"/><entity charOffset="33:71" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.5" text="enhance neuromuscular blocking effects" type="Specific_Interaction"><Normalization><mmtx cui="C0234119" phraseText="neuromuscular blocking effects of curariform drugs" preferredWord="Neuromuscular inhibition" semType="dsyn"/><mmtx cui="C0700323" phraseText="neuromuscular blocking effects of curariform drugs" preferredWord="Observation of Neuromuscular Block" semType="dsyn"/></Normalization></entity><entity charOffset="148:170" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.7" text="respiratory depression" type="Specific_Interaction"/><entity charOffset="194:199" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.9" text="apnea" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.1" drugClass="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.ddi.3"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.4" ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130" lineNumber="164" text="Accordingly, it may be advisable to discontinue ZAROXOLYN three days before elective surgery." type="irregular"><entity charOffset="48:57" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="ZAROXOLYN three days before elective surgery." preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130.e.1" text="discontinue" type="Caution_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129" text="Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. "><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.129.e.0"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.130.e.0"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131" text="Salicylates And Other Non-Steroidal Anti-Inflammatory Drugs" type="negative"><entity charOffset="0:11" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.0" text="salicylates" type="Biomedical_Entity"><Normalization><mmtx cui="C0036077" phraseText="Salicylates" preferredWord="Salicylates" semType="phsu, orch"/><RxNorm RxCui="9522"/></Normalization></entity><entity charOffset="22:59" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.1" text="non-steroidal anti-inflammatory drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C3536840" phraseText="Other Non-Steroidal Anti-Inflammatory Drugs" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132" lineNumber="168" text="May decrease the antihypertensive effects of ZAROXOLYN Tablets." type="irregular"><entity charOffset="4:41" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132.e.0" text="decrease the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="45:62" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132.e.2" text="ZAROXOLYN Tablets" type="Drug"><Normalization><mmtx cui="C1242748" phraseText="the antihypertensive effects of ZAROXOLYN Tablets." preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="203794"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131" text="Salicylates And Other Non-Steroidal Anti-Inflammatory Drugs"><entity charOffset="22:59" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.1" text="Non-Steroidal Anti-Inflammatory Drugs" type="Drug_Class"><Normalization><mmtx cui="C3536840" phraseText="Other Non-Steroidal Anti-Inflammatory Drugs" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.132.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131" text="Salicylates And Other Non-Steroidal Anti-Inflammatory Drugs"><entity charOffset="0:11" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.131.e.0" text="Salicylates" type="Drug_Class"><Normalization><mmtx cui="C0036077" phraseText="Salicylates" preferredWord="Salicylates" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134" lineNumber="172" text="Metolazone may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use." type="regular"><entity charOffset="0:10" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.0" text="Metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="Metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="51:65" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.1" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="arterial responsiveness to norepinephrine," preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="15:47" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.2" text="decrease arterial responsiveness" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.1" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.134.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.135" text="Insulin And Oral Antidiabetic Agents" type="negative"><entity charOffset="0:7" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.135.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021641" phraseText="Insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="17:36" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.135.e.1" text="antidiabetic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0935929" phraseText="Oral Antidiabetic Agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.135.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.135.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138" lineNumber="180" text="Efficacy may be decreased due to urinary alkalizing effect of metolazone." type="irregular"><entity charOffset="62:72" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138.e.0" text="metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="decreased due to urinary alkalizing effect of metolazone." preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="0:25" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138.e.1" text="Efficacy may be decreased" type="Specific_Interaction"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138.e.1"><relations><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.138.e.0"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.137" text="Methenamine"><entity charOffset="0:11" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.137.e.0" text="Methenamine" type="Drug"><Normalization><mmtx cui="C0025638" phraseText="Methenamine" preferredWord="Methenamine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140" lineNumber="184" text="Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants, dosage adjustments may be necessary." type="regular"><entity charOffset="0:10" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.0" text="Metolazone" type="Drug"><Normalization><mmtx cui="C0025854" phraseText="Metolazone," preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="29:52" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.1" text="thiazide-like diuretics" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="other thiazide-" preferredWord="Thiazides" semType="phsu, orch"/><mmtx cui="C0012798" phraseText="like diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="1026480"/></Normalization></entity><entity charOffset="58:97" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.3" text="affect the hypoprothrombinemic response" type="Specific_Interaction"><Normalization><mmtx cui="C0020640" phraseText="the hypoprothrombinemic response to anticoagulants," preferredWord="Inherited Factor II deficiency" semType="dsyn"/><mmtx cui="C3203356" phraseText="the hypoprothrombinemic response to anticoagulants," preferredWord="Factor II deficiency" semType="dsyn"/></Normalization></entity><entity charOffset="101:115" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.5" text="anticoagulants" type="Drug_Class"><Normalization><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="117:135" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.6" text="dosage adjustments" type="Caution_Interaction"/><drugClassMembership drug="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.0" drugClass="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.1"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.5" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.140.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.149" text="In a rat study, in which males were treated orally with metolazone at doses of 2, 10, and 50 mg/kg for 127 days prior to mating with untreated females, an increased number of resorption sites was observed in dams mated with males from the 50 mg/kg group. " type="negative"><entity charOffset="213:218" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.149.e.0" text="mated" type="Biomedical_Entity"><Normalization><mmtx cui="C1254211" phraseText="mated with males" preferredWord="Ilex paraguayensis homeopathic preparation" semType="phsu"/><RxNorm RxCui="590964"/></Normalization></entity><entity charOffset="56:66" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.149.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="orally with metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.149.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.149.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. " type="negative"><entity charOffset="66:76" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.0" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide in pediatric patients" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="104:114" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.1" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="with furosemide-resistant edema." preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.2" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="experience with the combination of ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.0"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176" lineNumber="222" text="Some benefited while others did not or had an exaggerated response with hypovolemia, tachycardia, and orthostatic hypotension requiring fluid replacement. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" Text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "/><anaphoraEntity charOffset="21:27" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.0" text="others" type="Expression"/><antecedentEntity charOffset="80:130" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.2" text="pediatric patients with furosemide-resistant edema" type="SPAN"/></anaphoraRelation><entity charOffset="72:83" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.2" text="hypovolemia" type="Specific_Interaction"/><entity charOffset="102:125" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.4" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="orthostatic hypotension requiring fluid replacement." preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.6" text="tachycardia" type="Specific_Interaction"/><entity charOffset="21:27" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.8" text="others" type="SPAN"/><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="66:76" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.1" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide in pediatric patients" preferredWord="Furosemide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="52:61" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="experience with the combination of ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.ddi.2"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="66:76" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.1" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide in pediatric patients" preferredWord="Furosemide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="52:61" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="experience with the combination of ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.ddi.3"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="66:76" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.1" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide in pediatric patients" preferredWord="Furosemide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175" text="There is limited experience with the combination of ZAROXOLYN and furosemide in pediatric patients with furosemide-resistant edema. "><entity charOffset="52:61" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.175.e.0" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="experience with the combination of ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.176.e.8"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.189" text="Many ZAROXOLYN related adverse reactions represent extensions of its expected pharmacologic activity and can be attributed to either its antihypertensive action or its renal/metabolic actions. " type="negative"><entity charOffset="5:14" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.189.e.0" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="Many ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="137:153" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.189.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="its antihypertensive action" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.189.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.189.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209" text="In addition, adverse reactions reported with similar antihypertensive-diuretics, but which have not been reported to date for ZAROXOLYN include: bitter taste, sialadenitis, xanthopsia, respiratory distress (including pneumonitis), and anaphylactic reactions. " type="negative"><entity charOffset="53:69" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="reported with similar antihypertensive-diuretics," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="126:135" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="for ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="reported with similar antihypertensive-diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.2"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.2" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.209.e.1"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.213" text="Intentional overdosage has been reported rarely with metolazone and similar diuretic drugs." type="negative"><entity charOffset="76:84" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.213.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="similar diuretic drugs." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="53:63" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.213.e.1" text="metolazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0025854" phraseText="rarely with metolazone" preferredWord="Metolazone" semType="phsu, orch"/><RxNorm RxCui="6916"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.213.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.213.e.0"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236" text="New patients MYKROX Tablets (metolazone tablets, USP) (see MYKROX package circular). " type="negative"><entity charOffset="13:19" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.0" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="New patients MYKROX Tablets" preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="29:47" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.1" text="metolazone tablets" type="Biomedical_Entity"><Normalization><mmtx cui="C1242748" phraseText="(metolazone tablets," preferredWord="Metolazone Oral Tablet [Zaroxolyn]" semType="clnd"/><RxNorm RxCui="6916"/></Normalization></entity><entity charOffset="59:65" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.2" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="MYKROX" preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.0" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.1"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.236.e.2"/></sentence><sentence id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.237" text="If considered desirable to switch patients currently on ZAROXOLYN to MYKROX, the dose should be determined by titration starting at one tablet (1/2 mg) once daily and increasing to two tablets (1 mg) once daily if needed." type="negative"><entity charOffset="69:75" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.237.e.0" text="mykrox" type="Biomedical_Entity"><Normalization><mmtx cui="C0701386" phraseText="to MYKROX," preferredWord="Mykrox" semType="phsu, orch"/><RxNorm RxCui="203798"/></Normalization></entity><entity charOffset="56:65" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.237.e.1" text="zaroxolyn" type="Biomedical_Entity"><Normalization><mmtx cui="C0701383" phraseText="patients currently on ZAROXOLYN" preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.237.e.1" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.237.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244" lineNumber="300" text="If antihypertensive drugs or diuretics are given concurrently with ZAROXOLYN, more careful dosage adjustment may be necessary. " type="regular"><entity charOffset="91:108" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.0" text="dosage adjustment" type="Caution_Interaction"/><entity charOffset="67:76" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.2" text="ZAROXOLYN" type="Drug"><Normalization><mmtx cui="C0701383" phraseText="concurrently with ZAROXOLYN," preferredWord="Zaroxolyn" semType="phsu, orch"/><RxNorm RxCui="203794"/></Normalization></entity><entity charOffset="3:25" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.3" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive drugs" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="29:38" id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.4" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.ddi.1"><interaction trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.4" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.2" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.2" trigger="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.3" e2="Dailymed.16026409-e821-4680-a114-24c1761d6690.s.244.e.4"/></sentence><positiveExamples number="23"/><negativeExamples number="101"/></document>